Molecular Neurodegeneration

official impact factor 5.36

Open Access

PGC-1alpha as modifier of onset age in Huntington disease

Elahe Taherzadeh-Fard, Carsten Saft, Jürgen Andrich, Stefan Wieczorek and Larissa Arning*

Molecular Neurodegeneration 2009, 4:10 doi:10.1186/1750-1326-4-10

Accesses  

  • Last 30 days: 53 accesses
  • Last year: 672 accesses
  • All time: 2490 accesses

Cited by

BioMed Central: 1 citation

Review   Free

Huntington's disease: the case for genetic modifiers

James F Gusella, Marcy E MacDonald Genome Med 2009, 1:80 (21 August 2009)

The search for genetic modifiers in Huntington’s disease offers insights into biochemical changes occurring years before diagnosis and may allow the identification of targets for therapeutic intervention.